New hope for young japanese patients with rare brain tumors: tovorafenib trial launches
NCT ID NCT07441707
First seen Mar 20, 2026 · Last updated Jun 17, 2026 · Updated 15 times
Summary
This study is testing a new drug called tovorafenib in Japanese children, adolescents, and young adults (ages 6 months to 25 years) with a specific type of brain tumor called low-grade glioma that has come back or is growing. The drug is taken once a week by mouth. The main goals are to check the drug's safety and how the body processes it. The study will also see if the drug can shrink the tumors. Participants will be treated for up to 24 months and followed for up to 4 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW GRADE GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hyogo Prefectural Kobe Children's Hospital
RECRUITINGKobe, Japan
-
Kanagawa Children's Medical Center
NOT_YET_RECRUITINGKanagawa, Japan
-
Kyoto University Hospital
RECRUITINGKyoto, Japan
-
National Cancer Center Hospital
RECRUITINGTokyo, Japan
-
National Center for Child Health and Development
RECRUITINGTokyo, Japan
-
Osaka City General Hospital
RECRUITINGOsaka, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.